|
Rheumatoid Arthritis
Citations 531-540 of 841 total displayed.
|
Past content
(since Feb 2000):
|
- CASE REPORTS
Bronchial MALT lymphoma in longstanding rheumatoid arthritis
- K. M. J. Douglas, K. Raza, R. Stevens, N. Erb, E. L. Jones, and G. D. Kitas
Rheumatology 2005; 44: 687-689.
[Extract]
[Full Text]
- CASE REPORTS
Survival and safety of treatment with infliximab in the elderly population
- H. Chevillotte-Maillard, P. Ornetti, R. Mistrih, C. Sidot, J. Dupuis, J.-A. Dellas, C. Tavernier, and J. F. Maillefert
Rheumatology 2005; 44: 695-696.
[Extract]
[Full Text]
- REVIEWS
Predictive and potentially predictive factors in early arthritis: a multidisciplinary approach
- P. Härle, T. Bongartz, J. Schölmerich, U. Müller-Ladner, and R. H. Straub
Rheumatology 2005; 44: 426-433.
[Abstract]
[Full Text]
- BASIC SCIENCE
An active metabolite of leflunomide, A77 1726, inhibits the production of serum amyloid A protein in human hepatocytes
- K. Migita, T. Miyashita, Y. Maeda, M. Nakamura, H. Yatsuhashi, H. Ishibashi, and K. Eguchi
Rheumatology 2005; 44: 443-448.
[Abstract]
[Full Text]
- CLINICAL
A dose adjustment in patients with rheumatoid arthritis not optimally responding to a standard dose of infliximab of 3 mg/kg every 8 weeks can be effective: a Belgian prospective study
- P. Durez, F. Van den Bosch, L. Corluy, E. M. Veys, L. De Clerck, A. Peretz, M. Malaise, J.-P. Devogelaer, N. Vastesaeger, A. Geldhof, and R. Westhovens
Rheumatology 2005; 44: 465-468.
[Abstract]
[Full Text]
- CLINICAL
The influence of previous and concomitant leflunomide on the efficacy and safety of infliximab therapy in patients with rheumatoid arthritis; a longitudinal observational study
- M. Flendrie, M. C. W. Creemers, P. M. J. Welsing, and P. L. C. M. van Riel
Rheumatology 2005; 44: 472-478.
[Abstract]
[Full Text]
[ Supplementary Data ]
- CLINICAL
The influence of a polymorphism at position –857 of the tumour necrosis factor  gene on clinical response to etanercept therapy in rheumatoid arthritis
- C. P. Kang, K. W. Lee, D. H. Yoo, C. Kang, and S. C. Bae
Rheumatology 2005; 44: 547-552.
[Abstract]
[Full Text]
- GUIDELINES
BSR guidelines on standards of care for persons with rheumatoid arthritis
- T. Kennedy, C. McCabe, G. Struthers, H. Sinclair, K. Chakravaty, D. Bax, M. Shipley, R. Abernethy, T. Palferman, and R. Hull
Rheumatology 2005; 44: 553-556.
[Extract]
[Full Text]
- CASE REPORTS
Folic acid supplementation during methotrexate treatment: nonsense?
- R. Manna, E. Verrecchia, M. Diaco, M. Montalto, G. Cammarota, and G. Gasbarrini
Rheumatology 2005; 44: 563-564.
[Extract]
[Full Text]
- REVIEWS
Anti-TNF- therapies: they are all the same (aren't they?)
- S. Mpofu, F. Fatima, and R. J. Moots
Rheumatology 2005; 44: 271-273.
[Extract]
[Full Text]
|
|
